1029364-75-7Moxifloxacin EP Impurity C (HCl salt)
● Auf Lager
| Katalog-Nr.:: | VL106003 |
|---|---|
| CAS-Nr.:: | 1029364-75-7 |
| Summenformel:: | C22H27ClFN3O4 |
| Molare Masse:: | 451.92 |
Zusätzliche Informationen zu CAS 1029364-75-7
Parent drug
MoxifloxacinIUPAC-Name
1-Cyclopropyl-8-ethoxy-6-fluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo [3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid HClPharmakopöe-Synonyme
Moxifloxacin Related Compound COther Synonyms
8-Ethoxy Moxifloxacin (HCl Salt); Moxifloxacin HCl Ethyl AnalogSMILES
CCOC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.ClInChI
InChI=1S/C22H26FN3O4.ClH/c1-2-30-21-18-14(20(27)15(22(28)29)10-26(18)13-5-6-13)8-16(23)19(21)25-9-12-4-3-7-24-17(12)11-25;/h8,10,12-13,17,24H,2-7,9,11H2,1H3,(H,28,29);1H/t12-,17+;/m0./s1Beschreibung
Moxifloxacin EP Impurity C (HCl salt) (CAS No: 1029364-75-7) or Moxifloxacin Related Compound C is an impurity present in the synthesis of moxifloxacin which is a quinolone antimicrobial that has a potent activity that completely suppresses the Mycobacterium tuberculosis.
References
Al Omari, Mahmoud M. H., et al. “Moxifloxacin Hydrochloride.†Profiles of Drug Substances, Excipients and Related Methodology, 2014, pp. 299–431, https://doi.org/10.1016/b978-0-12-800173-8.00007-6. ?Gumbo, Tawanda, et al. “Selection of a Moxifloxacin Dose That Suppresses Drug Resistance InMycobacterium Tuberculosis, by Use of an in Vitro Pharmacodynamic Infection Model and Mathematical Modeling.†The Journal of Infectious Diseases, vol. 190, no. 9, Nov. 2004, pp. 1642–51, https://doi.org/10.1086Angebot anfordern
„*“ zeigt erforderliche Felder an









